FIELD: medicine.
SUBSTANCE: present group of inventions relates to immunology. Streptococcus pneumoniae strains are deposited in the State collection of pathogenic microorganisms of pathogenicity of III-IV groups of the Federal state budgetary institution “Scientific Center for Expertise of Means of Medical Application” of the Ministry of Health of Russia under registration numbers 296, 297, 298. These strains have intraspecific cross-protective activity and can be used to produce protein-containing fractions. Disclosed is a method for producing protein-containing fractions from the above strains to develop pneumococcal vaccines. For this purpose the strain is cultured, microbial cells are separated by microfiltration and inactivated by dimethyl ketone with subsequent water extraction and ultrafiltration to obtain a protein fraction with molecular weight of 30-100 kDa and cool dehumidification.
EFFECT: obtaining effective preparations with intraspecific immunogenic activity with respect to the respective serotypes of S.pneumoniae, which can be used as a antipneumococcal vaccine of a wide spectrum of action.
4 cl, 1 dwg, 4 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
STREPTOCOCCUS PNEUMONIAE STRAIN SEROTYPE 19F | 2022 |
|
RU2804137C1 |
STRAIN STREPTOCOCCUS PNEUMONIAE SEROTYPE 15F | 2022 |
|
RU2784070C1 |
STREPTOCOCCUS PNEUMONIAE STRAIN SEROTYPE 19A | 2022 |
|
RU2791744C1 |
VACCINE FOR PNEUMOCOCCAL INFECTION CONTROL | 1995 |
|
RU2087156C1 |
METHOD FOR PREPARING PROTECTIVE PROTEIN-CONTAINING FRACTION OF MICROORGANISM | 2006 |
|
RU2311197C1 |
RECOMBINANT PLASMID DNA pSp-raPLY ENCODING THE SYNTHESIS OF RECOMBINANT ATOXIC PNEUMOLYSIN PROTEIN STREPTOCOCCUS PNEUMONIAE, STRAIN OF ESCHERICHIA coli M15/pSp-raPLY BEING A PRODUCER OF RECOMBINANT ATOXIC FORM OF PNEUMOLYSIN, AND PRODUCTION OF SAID PROTEIN FOR DEVELOPING A VACCINE PRODUCT FOR PREVENTING PNEUMOCOCCAL INFECTIONS | 2021 |
|
RU2782598C1 |
METHOD OF PRODUCING PROTECTIVE PROTEIN CONTAINING FRACTION OF BACTERIA | 2013 |
|
RU2533815C1 |
C-POLYSACCHARIDE-FREE CAPSULAR POLYSACCHARIDES OF STREPTOCOCCUS PNEUMONIAE WITH A 2,5-ANHYDROMANOSE RESIDUE AT THE REDUCING END | 2023 |
|
RU2818894C1 |
METHOD FOR FORMING IMMUNOLOGICAL MEMORY TO STREPTOCOCCUS PNEUMONIAE ANTIGENS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2014 |
|
RU2544168C1 |
IMMUNOBIOLOGICAL AGENT BASED ON RECOMBINANT PROTEIN FOR PREVENTING PNEUMOCOCCAL INFECTION | 2024 |
|
RU2823752C1 |
Authors
Dates
2016-10-27—Published
2015-05-12—Filed